Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
Dr. Hoang brings over 17 years of experience across multiple sectors of the global healthcare industry to Clearside. Prior to joining Clearside, Dr. Hoang was Vice President, Medical Affairs for
“Carol is a seasoned executive with a strong track record of success managing medical affairs for both large and emerging ophthalmic companies,” said Clearside’s Chief Executive Officer and President,
Cautionary Note Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe”, “expect”, “may”, “plan”, “potential”, “will”, and similar expressions, and are based on Clearside’s current beliefs and expectations. These forward-looking statements include expectations regarding Clearside transitioning from a clinical-stage company to a commercial-stage company, the potential clinical development of Clearside’s product candidates, the timing of a potential filing of an NDA with the
Chief Financial Officer
Source: Clearside Biomedical, Inc.